Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1953 2
1990 1
2006 1
2012 1
2013 2
2014 2
2016 1
2017 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
[Bioresorbable vascular scaffolds: clinical experience of the Emilia-Romagna Region, Italy].
Menozzi A, Campo GC, Guiducci V, Dall'Ara G, Santarelli A, Sbarzaglia P, Balducelli M, Magnavacchi P, Sgura F, Losi L, Vignali L, Casella G, Steffanon L, Tarantino F, Saia F. Menozzi A, et al. Among authors: steffanon l. G Ital Cardiol (Rome). 2017 Feb;18(2 Suppl 1):9S-18S. doi: 10.1714/2657.27243. G Ital Cardiol (Rome). 2017. PMID: 28398396 Italian.
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial.
Colombo A, Chieffo A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N, Oteo Dominguez JF, Steffanon L, Tarantini G, Presbitero P, Menozzi A, Pucci E, Mauri J, Cesana BM, Giustino G, Sardella G. Colombo A, et al. Among authors: steffanon l. J Am Coll Cardiol. 2014 Nov 18-25;64(20):2086-97. doi: 10.1016/j.jacc.2014.09.008. Epub 2014 Sep 15. J Am Coll Cardiol. 2014. PMID: 25236346 Free article. Clinical Trial.
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy.
Tarantini G, Nai Fovino L, Tellaroli P, Chieffo A, Barioli A, Menozzi A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N, Dominguez JF, Steffanon L, Presbitero P, Pucci E, Fraccaro C, Mauri J, Giustino G, Sardella G, Colombo A. Tarantini G, et al. Among authors: steffanon l. Int J Cardiol. 2016 Mar 15;207:168-76. doi: 10.1016/j.ijcard.2016.01.068. Epub 2016 Jan 11. Int J Cardiol. 2016. PMID: 26803236 Clinical Trial.
Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry.
Rubboli A, Saia F, Sciahbasi A, Bacchi-Reggiani ML, Steffanon L, Briguori C, Calabrò P, Palmieri C, Rizzi A, Imperadore F, Sangiorgi GM, Valgimigli M, Carosio G, Steffenino G, Galvani M, Di Pasquale G, La Vecchia L, Maggioni AP, Bolognese L; WARfarin and Coronary STENTing (WAR-STENT) Study Group. Rubboli A, et al. Among authors: steffanon l. J Invasive Cardiol. 2014 Nov;26(11):563-9. J Invasive Cardiol. 2014. PMID: 25363997 Free article.
Residual shunt after patent foramen ovale closure: preliminary results from Italian patent foramen ovale survey.
Caputi L, Butera G, Anzola GP, Carminati M, Carriero MR, Chessa M, Onorato E, Rigatelli G, Sangiorgi G, Santoro G, Spadoni I, Ussia GP, Vigna C, Zanchetta M, Parati E; Italian Patent Foramen Ovale Survey investigators. Caputi L, et al. J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e219-26. doi: 10.1016/j.jstrokecerebrovasdis.2012.12.002. Epub 2013 Jan 22. J Stroke Cerebrovasc Dis. 2013. PMID: 23352683
In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry.
Rubboli A, Sciahbasi A, Briguori C, Saia F, Palmieri C, Moroni LA, Calabrò P, Leone AM, Franco N, Valgimigli M, Varani E, Santi M, Pasqualini P, Capecchi A, Piccalò G, Margheri M, di Pasquale G, Galvani M, Bolognese L, Gonzini L, Maggioni AP; WARfarin and coronary STENTing registry. Rubboli A, et al. J Invasive Cardiol. 2013 Apr;25(4):170-6. J Invasive Cardiol. 2013. PMID: 23549489 Free article.
Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngiopLastiche dell'Emilia-Romagna) multicenter registry.
Valgimigli M, Saia F, Guastaroba P, Menozzi A, Magnavacchi P, Santarelli A, Passerini F, Sangiorgio P, Manari A, Tarantino F, Margheri M, Benassi A, Sangiorgi MG, Tondi S, Marzocchi A; REAL Registry Investigators. Valgimigli M, et al. JACC Cardiovasc Interv. 2012 Jan;5(1):23-35. doi: 10.1016/j.jcin.2011.08.018. JACC Cardiovasc Interv. 2012. PMID: 22230147 Free article.
Twelve-month outcome of patients with an established indication for oral anticoagulation undergoing coronary artery stenting and stratified by the baseline risk of bleeding: Insights from the Warfarin and Coronary Stenting (War-Stent) Registry.
Rubboli A, Saia F, Sciahbasi A, Leone AM, Palmieri C, Bacchi-Reggiani ML, Calabrò P, Bordoni B, Piccalò G, Franco N, Nicolino A, Magnavacchi P, Vignali L, Mameli S, Dallago M, Maggiolini S, Steffanon L, Piovaccari G, Di Pasquale G; WARfarin and Coronary STENTing (WAR-STENT) Study group. Rubboli A, et al. Among authors: steffanon l. Cardiovasc Revasc Med. 2017 Sep;18(6):425-430. doi: 10.1016/j.carrev.2017.03.015. Epub 2017 Mar 19. Cardiovasc Revasc Med. 2017. PMID: 28363682
[Postural tonus in pyramidal cat].
ROSSI GF, STEFFANON L. ROSSI GF, et al. Among authors: steffanon l. Arch Fisiol. 1953 May;52(4):407-13. Arch Fisiol. 1953. PMID: 13081328 Undetermined Language. No abstract available.
14 results